Page last updated: 2024-08-24

saperconazole and Candidiasis, Vulvovaginal

saperconazole has been researched along with Candidiasis, Vulvovaginal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cauwenbergh, G; De Beule, K; Dhondt, A; Van Cutsem, J1

Trials

1 trial(s) available for saperconazole and Candidiasis, Vulvovaginal

ArticleYear
Phase II trial: an evaluation of oral saperconazole in acute vaginal candidosis: a comparison of three dosage schedules.
    European journal of obstetrics, gynecology, and reproductive biology, 1991, Oct-08, Volume: 41, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Azoles; Candidiasis, Vulvovaginal; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged

1991